These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1664125)

  • 1. Clinical studies with herpes simplex virus type 2 Curtis strain vaccine.
    Corey L
    Rev Infect Dis; 1991; 13 Suppl 11():S904-5. PubMed ID: 1664125
    [No Abstract]   [Full Text] [Related]  

  • 2. Double-blind, placebo-controlled trial of a herpes simplex virus type 2 glycoprotein vaccine in persons at high risk for genital herpes infection.
    Mertz GJ; Ashley R; Burke RL; Benedetti J; Critchlow C; Jones CC; Corey L
    J Infect Dis; 1990 Apr; 161(4):653-60. PubMed ID: 2181031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes.
    Stanberry LR; Bernstein DI; Burke RL; Pachl C; Myers MG
    J Infect Dis; 1987 May; 155(5):914-20. PubMed ID: 3031173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Herpes simplex virus vaccines.
    Meignier B; Roizman B
    Antiviral Res; 1985; Suppl 1():259-65. PubMed ID: 3002260
    [No Abstract]   [Full Text] [Related]  

  • 5. Clinical efficacy of a herpes simplex subunit vaccine.
    Cappel R; Sprecher S; De Cuyper F; De Braekeleer J
    J Med Virol; 1985 Jun; 16(2):137-45. PubMed ID: 2989419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombinant glycoprotein vaccine for the prevention of genital HSV-2 infection: two randomized controlled trials. Chiron HSV Vaccine Study Group.
    Corey L; Langenberg AG; Ashley R; Sekulovich RE; Izu AE; Douglas JM; Handsfield HH; Warren T; Marr L; Tyring S; DiCarlo R; Adimora AA; Leone P; Dekker CL; Burke RL; Leong WP; Straus SE
    JAMA; 1999 Jul; 282(4):331-40. PubMed ID: 10432030
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of vaccination with Skinner vaccine towards the prevention of herpes simplex virus induced cervical carcinoma in an experimental mouse model.
    Chen MH; Zhou Z; Hartley CE; Cowan M; Skinner GR
    Vaccine; 1986 Dec; 4(4):249-52. PubMed ID: 3026107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D.
    Berman PW; Gregory T; Crase D; Lasky LA
    Science; 1985 Mar; 227(4693):1490-2. PubMed ID: 2983428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody reactivity with Skinner HSV vaccine.
    Muniu EM; Durham J; Shariff D; Hartley CE; Fuller A; Melling J; Wiblin C; Wilkins G; Buchan A; Skinner GR
    Med Microbiol Immunol; 1987; 176(6):315-27. PubMed ID: 2828898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preparation and immunogenicity of vaccine Ac NFU1 (S-) MRC towards the prevention of herpes genitalis.
    Skinner GR; Woodman CB; Hartley CE; Buchan A; Fuller A; Durham J; Synnott M; Clay JC; Melling J; Wiblin C; Wilkins J
    Br J Vener Dis; 1982 Dec; 58(6):381-6. PubMed ID: 6293640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use.
    Burke RL
    Rev Infect Dis; 1991; 13 Suppl 11():S906-11. PubMed ID: 1664126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy of recombinant glycoprotein D subunit vaccines on the development of primary, recurrent, and latent genital infections with herpes simplex virus type 2 in guinea pigs.
    Berman PW; Vogt PE; Gregory T; Lasky LA; Kern ER
    J Infect Dis; 1988 May; 157(5):897-902. PubMed ID: 2834467
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunologic strategies for herpes vaccination.
    Friedman HM
    JAMA; 2000 Feb; 283(6):746; author reply 746-7. PubMed ID: 10683051
    [No Abstract]   [Full Text] [Related]  

  • 14. Herpes simplex virus type 1-vaccinia virus recombinant expressing glycoprotein B: protection from acute and latent infection.
    Willey DE; Cantin EM; Hill LR; Moss B; Notkins AL; Openshaw H
    J Infect Dis; 1988 Dec; 158(6):1382-6. PubMed ID: 2848904
    [No Abstract]   [Full Text] [Related]  

  • 15. Report of twelve years experience in open study of Skinner herpes simplex vaccine towards prevention of herpes genitalis.
    Skinner GR; Fink C; Melling J; Wiblin C; Thornton B; Hallworth J; Gardner W; McLeish P; Hartley C; Buchan A
    Med Microbiol Immunol; 1992; 180(6):305-20. PubMed ID: 1549071
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native herpes simplex virus glycoprotein D vaccine: immunogenicity and protection in animal models.
    Mishkin EM; Fahey JR; Kino Y; Klein RJ; Abramovitz AS; Mento SJ
    Vaccine; 1991 Mar; 9(3):147-53. PubMed ID: 1645898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A virus-particle vaccine prepared from bovine mammillitis virus against herpes genitalis.
    Skinner GR; Buchan A; Davies J; Durham J; Castrucci G
    Comp Immunol Microbiol Infect Dis; 1991; 14(2):133-50. PubMed ID: 1657508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccine induced HSV 1 antibodies fail to correlate with protection against HSV 2 in guinea pigs.
    Welch MJ; Ridgeway PH; Phillpotts RJ
    FEMS Microbiol Immunol; 1988 Dec; 1(3):157-62. PubMed ID: 2856207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Limited antibody-dependent cellular cytotoxicity antibody response induced by a herpes simplex virus type 2 subunit vaccine.
    Kohl S; Charlebois ED; Sigouroudinia M; Goldbeck C; Hartog K; Sekulovich RE; Langenberg AG; Burke RL
    J Infect Dis; 2000 Jan; 181(1):335-9. PubMed ID: 10608784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early experience with "antigenoid" vaccine Ac NFU1(S-) MRC towards prevention or modification of herpes genitalis.
    Skinner GR; Woodman C; Hartley C; Buchan A; Fuller A; Wiblin C; Wilkins G; Melling J
    Dev Biol Stand; 1982; 52():333-44. PubMed ID: 6299842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.